These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 319900)

  • 21. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
    Khoury-Collado F; St Clair C; Abu-Rustum NR
    Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor size in endometrial cancer.
    Schink JC; Rademaker AW; Miller DS; Lurain JR
    Cancer; 1991 Jun; 67(11):2791-4. PubMed ID: 2025843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case against Wertheim's hysterectomy in endometrial carcinoma.
    de Mûelenaere GF
    J Obstet Gynaecol Br Commonw; 1973 Aug; 80(8):728-34. PubMed ID: 4725951
    [No Abstract]   [Full Text] [Related]  

  • 24. Management and results of endometrial carcinoma treated at Instituto Português de Oncologia de Francisco Gentil.
    Tavares MA; Patricio MB; Vilhena M; Da Silva JN
    Cancer; 1977 Feb; 39(2):675-80. PubMed ID: 402190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A contemporary review of uterine cancer management.
    Carter J
    Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):517-24. PubMed ID: 23829412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histomorphologic prognostic factors in stage I endometrial cancers].
    Köhler U; Bilek K; Rosenkranz M
    Zentralbl Gynakol; 1987; 109(20):1245-54. PubMed ID: 3425025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy of uterine clear cell carcinoma: a review.
    Xu Y; Hanna RK; Elshaikh MA
    Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
    Siesto G; Romano F; Fiamengo B; Vitobello D
    J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial carcinoma: the role of irradiation.
    Underwood PB; Taylor PT
    Clin Obstet Gynaecol; 1986 Dec; 13(4):767-87. PubMed ID: 3791830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis.
    Isrow D; Burmeister C; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():115-120. PubMed ID: 27838535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stage I endometrial adenocarcinoma: treatment results in 835 patients.
    Lotocki RJ; Copeland LJ; DePetrillo AD; Muirhead W
    Am J Obstet Gynecol; 1983 May; 146(2):141-5. PubMed ID: 6846429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment variables in the management of endometrial cancer.
    Figge DC; Otto PM; Tamimi HK; Greer BE
    Am J Obstet Gynecol; 1983 Jul; 146(5):495-500. PubMed ID: 6859175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment failure sites according to irradiation technique and histology in patients with endometrial cancer.
    Landgren RD; Fletcher GH; Gallager HS; Declos L; Wharton JT
    Cancer; 1977 Jul; 40(1):131-5. PubMed ID: 880546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial cancer: rising incidence, detection and treatment.
    Kistner RW; Krantz KE; Lebherz TB; Lewis GL; Reagan JW; Smith J; Tobin JJ; Wied GL
    J Reprod Med; 1973 Feb; 10(2):53-74. PubMed ID: 4697433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy.
    DiSaia PJ; Creasman WT
    Clin Obstet Gynaecol; 1986 Dec; 13(4):751-65. PubMed ID: 3791829
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
    Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
    Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A clinicopathologic evaluation of "depth" in cases of endometrial adenocarcinoma].
    Sakamoto A; Hirai Y; Yamauchi K; Masubuchi K; Hasumi K
    Gan No Rinsho; 1990 May; 36(6):711-4. PubMed ID: 2348558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of irradiation on mixed müllerian tumors of the uterus.
    Perez CA; Askin F; Baglan RJ; Kao MS; Kraus FT; Perez BM; Williams CF; Weiss D
    Cancer; 1979 Apr; 43(4):1274-84. PubMed ID: 221087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients.
    Aalders J; Abeler V; Kolstad P; Onsrud M
    Obstet Gynecol; 1980 Oct; 56(4):419-27. PubMed ID: 6999399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.